Ann: Combined FOXFIRE Analysis Shows No Improvement in Survival, page-49

There is a lot of misinformation in the market at the moment, get this one from the SMH see below.
"Weak sales, particularly in the US has caused significant unease among investors, particularly since UK drugs group BTG, which has a rival product to the Sirtex treatment, earlier this week disclosed 16 per cent sales growth for its product.
"This is obviously a concern," Mr Lan(g)e (Fairfax: sic) said when asked about the success of BTG in boosting sales, as Sirtex continues to languish."

Now that 16% that so concerns the Sydney Morning Herald was expected to be 26% and Dame Makin in the earnings call passed over the TheraSpheres sales to speak of Galil indicating BTG was not interested in growing TheraSpheres much further.

Lange was actually answering a question about competitors: he must say he is concerned about competition. Which CEO does not say that so the journalism is misleading to suggest otherwise IMHO but pls DYOR.
http://www.smh.com.au/business/sirtex-shares-dumped-on-poor-research-outcome-20170518-gw7pjk.html